ArticlePediatric cardiology2026
Factors Influencing Weight Gain at Different Stages of the Fontan Pathway for Children with Functionally Single Ventricle Heart Disease.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Outcomes for functionally single ventricle heart (f-SV) conditions rely on careful management of staged surgical palliation. Studies report a decrease in weight-for-age z-score (WAZ) before Stage 2 (Glenn) procedure, with weight gain thereafter, however factors influencing WAZ changes remain unclear. Using National Congenital Heart Disease Audit data, we developed regression models to explore WAZ changes from Stage 1 (S1) to Stage 2 (S2), and S2 to Stage 3 (S3), on the single ventricle (Fontan) pathway for 3292 operated f-SV patients born 2000 to 2018 in England and Wales. Mean WAZ decreased from - 1.20 (SD 1.60) at S1 to - 1.47 (SD 1.32) at S2, with recovery to - 0.57 (SD 1.16) by S3 Fontan-type surgery. In a multivariable model including 2012 children surviving to S2, female sex and older age at S1 were associated with increased WAZ from S1 to S2 while non-cardiac anomalies and higher WAZ at S1 were associated with decreasing WAZ. In a second model, including 1244 survivors to S3, weight gain between S2 and S3 was associated with preterm birth and Black ethnicity; whereas female sex, unbalanced AVSD diagnosis, older age or higher WAZ at S2, and greater weight gain between S1 and S2 were associated with WAZ decrease. Analyses confirmed that mean WAZ decreases prior to S2, increases after S2 surgery, and is influenced by age and weight at each procedure. Factors associated with weight gain varied across the single ventricle pathway. Further investigation is needed to understand wider influences on growth, including intensive interstage nutrition.
Indexed as
Identifiers
42455298What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.